Endodontic Devices Market is Contracting to Reach a Sensational CAGR of 5.34% During Forecast 2018-2023


Market Highlights:
Newborns are prone to infections, which can occur at any time from the time of birth. The term newborn screening is widely used to describe various tests that occur during the first few hours or days of a newborn’s life and which, when properly timed and performed, has the potential to prevent severe health problems, including death. Factors such as an increase in incidences of newborn diseases, growing awareness among the population results in the growth of the market, Also, the increase in demand for newborn diagnosis, technological advancements to boost the growth of the market, new entrants in the market and government initiatives to bolster the growth of the market. However, other factors such as socio-economic issues extremely affect the market, lack of skilled and trained professionals, lack of healthcare infrastructure hinders the growth of the market. The global new-born screening market is expected to register a significant growth of 10.5% CAGR during the forecast period (2018–2023).
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6561
Key Players:
Some of the key players in the global new-born screening market are
·         AB Sciex LLC
·         Perkinelmer, Inc
·         Waters Corporation
·         Natus Medical Incorporated
·         Masimo Corporation
·         Agilent Technologies Inc
·         Bio-Rad Laboratories
·         Covidien PLC
·         GE Healthcare
·         Trivitron Healthcare
·         ZenTech S.A
Segmentation:
·         The global new-born screening market has been segmented on the basis of technology, test type, product and end users.
·         On the basis of technology, the market has been classified as tandem mass spectrometry (TMS), electrophoresis, immunoassays, and enzymatic assays, DNA-based assays, hearing screening technology, pulse oximetry screening technology.
·         On the basis of test type, the market has been classified as a dry blood spot test, hearing screening test, critical congenital heart diseases (CCHD) test, urine test, and others.
·         On the basis of products, the market has been classified as instruments and reagents and assay kits. The instruments have been segmented into the mass spectrometer, laparoscope, retinoscope, ultrasound machine, new-born hearing screening instruments, pulse oximeters. The new-born hearing screening instruments segment has been further segmented into hearing screening devices and hearing screening accessories.
·         On the basis of end users, the market has been classified as hospitals, maternity & specialty clinics, diagnostic centers, and others.
Regional Analysis:
The Americas is projected to lead the newborn screening market in the forecast period. Increasing healthcare awareness, advancement in technology, medical tourism are some other factors that boost the growth of the market. According to the American Academy of Pediatrics (AAP), every year 4.1 million newborns are screened for congenital disorders in the United States (U.S). Among these, 4,000 infants are diagnosed with congenital disorders and It is estimated that another 1,000 infants having congenital disorders go undetected.
The European market is expected to hold the second largest market share. Growing government funding in Europe for newborn screening within a national health service or a statutory health insurance is expected to drive newborn screening market growth in Europe. As per European Surveillance of Congenital Anomalies (EUROCAT), the occurrence of these abnormalities in every 24 births out of 1,000 is currently observed. In 2010, the World Health Organization (WHO) had undertaken a resolution of preventing these deaths by developing strong surveillance systems. Such measures are likely to contribute to the growth of the market over the forecast period.
Asia-Pacific is projected to be the fastest growing region for the global new-born screening market in 2018. It is expected to witness profitable growth over the forecast period due to the existence of favorable healthcare schemes drafted by government agencies. Awareness programs and quality assurance of newborn diagnostic procedures have added importance in the developing economies of Korea, Taiwan, China, Sri Lanka, and India since the last few years.
The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income. The strict regulatory environment in certain countries, the absence of technologically advanced instruments, interruptions and delays in hospitalization are major restraining factors for the global newborn screening market.
Access Report Details and Full TOC Exclusively  @ https://www.marketresearchfuture.com/reports/new-born-screening-market-6561
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more